Literature DB >> 14752334

The autoinflammatory syndromes.

Michael F McDermott1, Ivona Aksentijevich.   

Abstract

PURPOSE OF REVIEW: To review the remarkable recent progress in our understanding of a range of inflammatory conditions in humans that until recently appeared unrelated. The term autoinflammatory disease has been proposed to describe a group of disorders characterized by attacks of seemingly unprovoked inflammation without significant levels of autoantibodies and autoreactive T cells. RECENT
FINDINGS: As the link between the innate immune response and disease susceptibility has become more apparent, some remarkable associations have emerged. The majority of hereditary periodic fevers are due to mutations in the pyrin and tumour necrosis factor receptor superfamilies of molecules, both of which are intimately involved in innate immunity. Pyrin/marenostrin protein is mutated in familial Mediterranean fever, while mutations in a related protein, cryopyrin, are associated with Muckle-Wells/familial cold urticaria and chronic infantile neurologic cutaneous and articular syndrome. Both of these proteins interact with the apoptotic speck-like protein involved in caspase-1 activation and regulation of nuclear factor kappa B transcription; furthermore cryopyrin contains regions of homology with the nucleotide-binding oligomerization domain 2 protein, which is associated with susceptibility to Crohn's disease. Variants in the leucine-rich repeat domain of nucleotide-binding oligomerization domain are found in approximately 20% of patients with Crohn's disease, depending on ethnic background, while mutations in the NACHT domain are associated with a rare dominant granulomatous disease called Blau syndrome.
SUMMARY: The study of autoinflammatory disease has progressed from genetics to definition of the functional defects in these patients. Although a direct association between defective innate immune responses to bacterial components and these diseases has not been formally established, much ongoing research is aimed towards confirmation of that hypothesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14752334     DOI: 10.1097/00130832-200212000-00006

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  30 in total

Review 1.  Inflammasome-mediated autoinflammatory disorders.

Authors:  Shruti P Wilson; Suzanne L Cassel
Journal:  Postgrad Med       Date:  2010-09       Impact factor: 3.840

2.  Autoinflammation. Management of hereditary recurrent fevers--SHARE experience.

Authors:  Guillaume Sarrabay; Isabelle Touitou
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

3.  Hypercoagulability: interaction between inflammation and coagulation in familial Mediterranean fever.

Authors:  Guzide Aksu; Can Ozturk; Kaan Kavakli; Ferah Genel; Necil Kutukculer
Journal:  Clin Rheumatol       Date:  2006-05-24       Impact factor: 2.980

4.  The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals.

Authors:  Kristi L Williams; John D Lich; Joseph A Duncan; William Reed; Prasad Rallabhandi; Christopher Moore; Sherry Kurtz; V McNeil Coffield; Mary A Accavitti-Loper; Lishan Su; Stefanie N Vogel; Miriam Braunstein; Jenny P-Y Ting
Journal:  J Biol Chem       Date:  2005-10-03       Impact factor: 5.157

Review 5.  Inflammasomes in Myeloid Cells: Warriors Within.

Authors:  Sushmita Jha; W June Brickey; Jenny Pan-Yun Ting
Journal:  Microbiol Spectr       Date:  2017-01

Review 6.  Moving towards a systems-based classification of innate immune-mediated diseases.

Authors:  Sinisa Savic; Emily A Caseley; Michael F McDermott
Journal:  Nat Rev Rheumatol       Date:  2020-02-27       Impact factor: 20.543

Review 7.  Inflammasomes in the pathophysiology of autoinflammatory syndromes.

Authors:  Sarang Tartey; Thirumala-Devi Kanneganti
Journal:  J Leukoc Biol       Date:  2019-10-14       Impact factor: 4.962

Review 8.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

9.  ATP binding by monarch-1/NLRP12 is critical for its inhibitory function.

Authors:  Zhengmao Ye; John D Lich; Chris B Moore; Joseph A Duncan; Kristi L Williams; Jenny P-Y Ting
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

10.  Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap).

Authors:  Leigh D Church; Sinisa Savic; Michael F McDermott
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.